| 1 |
34244479 | MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. | 2021 Jul 9 |
1 |
| 2 |
32559715 | Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma. | 2020 Jul |
1 |
| 3 |
30503555 | Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma. | 2019 Feb 28 |
1 |
| 4 |
27015562 | [Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling. | 2016 Apr 26 |
1 |
| 5 |
25451688 | Oncogenic c-Myc and prothymosin-alpha protect hepatocellular carcinoma cells against sorafenib-induced apoptosis. | 2015 Jan 1 |
5 |
| 6 |
25862630 | Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo. | 2015 Jul |
1 |
| 7 |
26622569 | Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma. | 2015 Aug |
1 |
| 8 |
20054642 | Synergistic activity of letrozole and sorafenib on breast cancer cells. | 2010 Nov |
1 |